Kolb, Martin http://orcid.org/0000-0003-3837-1467
Vašáková, Martina
Funding for this research was provided by:
Boehringer Ingelheim (N/A)
Article History
Received: 16 January 2019
Accepted: 4 March 2019
First Online: 14 March 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Martin Kolb reports receipt of grants and personal fees from Boehringer Ingelheim and Roche; personal fees from GlaxoSmithKline, Gilead, AstraZeneca, ProMetic and Genoa; and grants from Actelion, Respivert, the Canadian Institutes of Health Research (MOP-136950), and the Canadian Pulmonary Fibrosis Foundation. Martina Vašáková has received payment for consultancy, lectures and advisory board attendance from Roche and Boehringer Ingelheim and has received research grants from Roche.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.